Table 1.

Antibacterial activity of newly synthesized compounds (inhibition zones, mm).

Comp. No	E. Coli	Ba. anthracic	St. aureus
2a	-	15	10
2b	11	15	17
2c	-	14	20
2d	13	10	3
2e	18	14	5
2f	15	18	4
2g	16	15	10
2h	12	10	10
3a	18	17	23
3b	10	15	7
3c	10	11	17
3d	10	15	10
3e	14	15	3
3f	13	10	17
3g	12	10	7
Cefazolin	13	8	6